BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 6419124)

  • 21. Activation of the c-myc oncogene by the immunoglobulin heavy-chain gene enhancer after multiple switch region-mediated chromosome rearrangements in a murine plasmacytoma.
    Fahrlander PD; Sümegi J; Yang JQ; Wiener F; Marcu KB; Klein G
    Proc Natl Acad Sci U S A; 1985 Jun; 82(11):3746-50. PubMed ID: 2987943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The intron enhancer of the immunoglobulin kappa gene activates c-myc but does not induce the Burkitt-specific promoter shift.
    Polack A; Strobl L; Feederle R; Schweizer M; Koch E; Eick D; Wiegand H; Bornkamm GW
    Oncogene; 1991 Nov; 6(11):2033-40. PubMed ID: 1945409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nucleotide sequence of immunoglobulin heavy chain joining segments between translocated VH and mu constant regions genes.
    Bernard O; Gough NM
    Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3630-4. PubMed ID: 6251474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variable IgH chain enhancer activity in Burkitt's lymphomas suggests an additional, direct mechanism of c-myc deregulation.
    Jain VK; Judde JG; Max EE; Magrath IT
    J Immunol; 1993 Jun; 150(12):5418-28. PubMed ID: 8515068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The mechanism of inactivation of the normal c-myc gene locus in human Burkitt lymphoma cells.
    Nishikura K; Murray JM
    Oncogene; 1988 May; 2(5):493-8. PubMed ID: 3131718
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel alteration in the structure of an activated c-myc gene in a variant t(2;8) Burkitt lymphoma.
    Taub R; Kelly K; Battey J; Latt S; Lenoir GM; Tantravahi U; Tu Z; Leder P
    Cell; 1984 Jun; 37(2):511-20. PubMed ID: 6327071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of immunoglobulin kappa elements in c-myc activation.
    Hörtnagel K; Mautner J; Strobl LJ; Wolf DA; Christoph B; Geltinger C; Polack A
    Oncogene; 1995 Apr; 10(7):1393-401. PubMed ID: 7731690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunoglobulin heavy chain enhancer is located near or in an initiation zone of chromosomal DNA replication.
    Ariizumi K; Wang Z; Tucker PW
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3695-9. PubMed ID: 8475117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A lymphocyte-specific cellular enhancer is located downstream of the joining region in immunoglobulin heavy chain genes.
    Banerji J; Olson L; Schaffner W
    Cell; 1983 Jul; 33(3):729-40. PubMed ID: 6409418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered nucleotide sequences of a translocated c-myc gene in Burkitt lymphoma.
    Rabbitts TH; Hamlyn PH; Baer R
    Nature; 1983 Dec 22-1984 Jan 4; 306(5945):760-5. PubMed ID: 6419122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coexpression of translocated and normal c-myc oncogenes in hybrids between Daudi and lymphoblastoid cells.
    Croce CM; Erikson J; Huebner K; Nishikura K
    Science; 1985 Mar; 227(4691):1235-8. PubMed ID: 3856319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of the c-myc p1 promoter in Burkitt's lymphoma by the hs3 immunoglobulin heavy-chain gene enhancer.
    Hu HM; Kanda K; Zhang L; Boxer LM
    Leukemia; 2007 Apr; 21(4):747-53. PubMed ID: 17287852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two antisense promoters in the immunoglobulin mu-switch region drive expression of c-myc in the Burkitt's lymphoma cell line BL67.
    Apel TW; Mautner J; Polack A; Bornkamm GW; Eick D
    Oncogene; 1992 Jul; 7(7):1267-71. PubMed ID: 1620543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chromatin structural changes in the putative regulatory region of c-myc accompany the translocation in a Burkitt lymphoma.
    Siebenlist U; Hennighausen L; Battey J; Leder P
    Curr Top Microbiol Immunol; 1984; 113():183-9. PubMed ID: 6434235
    [No Abstract]   [Full Text] [Related]  

  • 35. The c-MYC allele that is translocated into the IgH locus undergoes constitutive hypermutation in a Burkitt's lymphoma line.
    Bemark M; Neuberger MS
    Oncogene; 2000 Jul; 19(30):3404-10. PubMed ID: 10918597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chromatin structure around the c-myc gene in Burkitt lymphomas with upstream and downstream translocation points.
    Dyson PJ; Rabbitts TH
    Proc Natl Acad Sci U S A; 1985 Apr; 82(7):1984-8. PubMed ID: 3856876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNase I hypersensitive sites in the chromatin of human mu immunoglobulin heavy-chain genes.
    Mills FC; Fisher LM; Kuroda R; Ford AM; Gould HJ
    Nature; 1983 Dec 22-1984 Jan 4; 306(5945):809-12. PubMed ID: 6419125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Different regions of the immunoglobulin heavy-chain locus are involved in chromosomal translocations in distinct pathogenetic forms of Burkitt lymphoma.
    Neri A; Barriga F; Knowles DM; Magrath IT; Dalla-Favera R
    Proc Natl Acad Sci U S A; 1988 Apr; 85(8):2748-52. PubMed ID: 2833750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The t(8;14) chromosome translocation of the Burkitt lymphoma cell line Daudi occurred during immunoglobulin gene rearrangement and involved the heavy chain diversity region.
    Haluska FG; Tsujimoto Y; Croce CM
    Proc Natl Acad Sci U S A; 1987 Oct; 84(19):6835-9. PubMed ID: 3116544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amplification of the translocated c-myc genes in three Burkitt lymphoma cell lines.
    Khaira P; James CD; Leffak M
    Gene; 1998 Apr; 211(1):101-8. PubMed ID: 9643977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.